AbCellera is a Canadian biotechnology company focused on antibody drug discovery and development using its integrated technology platform. While they are building internal GMP manufacturing capability (130,000 sqft planned facility in Vancouver), their primary business is developing their own internal pipeline of antibody medicines, not providing contract manufacturing services to third parties.
antibody discovery platform, GPCR/ion channel targeting, bispecific antibodies, antibody drug conjugates, internal pipeline development
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.